Information Provided By: 
Fly News Breaks for April 20, 2018
MDSO
Apr 20, 2018 | 05:56 EDT
JPMorgan analyst Sterling Auty views Medidata Solutions' Q1 as a step in the right direction with subscription revenue beating and growth of almost 18%. He expects further acceleration throughout the rest of the year and keeps an Overweight rating on the shares with an $87 price target. The results should be the start of the catalyst to take shares higher, Auty tells investors in a post-earnings research note titled "Subscription Upside a Positive Signal."
News For MDSO From the Last 2 Days
There are no results for your query MDSO
